Hemoglobin Decrease With Iron Deficiency Induced by Daclatasvir Plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

PLoS ONE - United States
doi 10.1371/journal.pone.0151238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir Plus Asunaprevir Treatment

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2020English

Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report

BMC Nephrology
Nephrology
2017English

Association of IL-1β, IL-1RN, and ESR1 Genes Polymorphism With Risk of Infection and Response to Sofosbuvir Plus Daclatasvir Combination Therapy in Hepatitis C Virus Genotype-4 Patients

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients With Genotype 1b and High Virus Load

Internal Medicine
Internal MedicineMedicine
2010English

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants During SOF/LDV Combination Therapy Against Genotype 1b Hepatitis C Virus (HCV)

Scientific Reports
Multidisciplinary
2017English

Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 3a in Pakistani Population - A Real World Experience

Pakistan Journal of Medical Sciences
Medicine
2019English

Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy